Larvol Delta - Enhertu-and-Datroway-Approved-in-Japan-for-Two-New-FirstLine-Indications-for-Patients-with-Metastatic-Breast-Cancer

Datroway (datopotamab deruxtecan-dlnk) - Daiichi Sankyo, AstraZeneca

Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca

https://www.daiichisankyo.com/files/news/pressrelease/pdf/202609/20260916_E.pdf

Sep 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next